FDA Approves Basal-IQ Predictive Low Suspend for the t:slim X2 Pump from Tandem
Tandem announces FDA approval of the Basal-IQ™ technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events for the t:slim X2™ Insulin Pump.READ MORE
